Order by most recent / most popular / relevance
Results: 1-10 of 392
In November, the Supreme Court issued its decision in the sildenafil case, and, as part of its order, found the patent to be invalid. As this case was
Bayer sought to prohibit the Minister of Health from issuing a Notice of Compliance to Cobalt for a generic version of Bayer’s oral contraceptive
In this case, Apotex claimed damages pursuant to s. 8 of the NOC Regulations, and Pfizer alleged that Apotex should not be entitled to damages, due
The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal
This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the
The Court of Appeal has overturned a lower court decision and struck the mark NEOWEB from the register because it is confusing with the earlier
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
The governments of a number of provinces sought judicial review of a decision of the Copyright Board of Canada dismissing their objection that the
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
The Federal Court found Teva’s allegations of invalidity were not justified for Novartis’ narrow compound patent, while the allegations against
